These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36216753)

  • 21. Pharmacists' experiences and views on providing screening services: An international comparison.
    Alzubaidi H; Namara KM; Saidawi W; Hasan S; Krass I
    Res Social Adm Pharm; 2020 Nov; 16(11):1558-1568. PubMed ID: 32830071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring barriers and facilitators to pharmacist-provided diabetes self-management education and support.
    Gawlik G; Nguyen E; Robinson R
    J Am Pharm Assoc (2003); 2023; 63(1):74-79. PubMed ID: 36114100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the role of practice pharmacists in Australia: a mixed methods study.
    Baker S; Lee YP; Hattingh HL
    Int J Clin Pharm; 2019 Apr; 41(2):504-515. PubMed ID: 30879214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
    Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
    Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives of community pharmacists in Pakistan about practice change and implementation of extended pharmacy services: a mixed method study.
    Hashmi F; Hassali MA; Saleem F; Saeed H; Islam M; Malik UR; Atif N; Babar ZU
    Int J Clin Pharm; 2021 Aug; 43(4):1090-1100. PubMed ID: 33411180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient and prescriber perceptions of depression screening within a community pharmacy setting.
    Mospan CM; Gillette C; Wilson JA
    J Am Pharm Assoc (2003); 2020; 60(5S):S15-S22. PubMed ID: 32280022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study.
    Marquis J; Schneider MP; Spencer B; Bugnon O; Du Pasquier S
    Int J Clin Pharm; 2014 Oct; 36(5):1014-22. PubMed ID: 25139136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia.
    Selvaraj A; Redzuan AM; Hatah E
    Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community pharmacy-based injectable naltrexone service delivery models and best practices.
    Ford JH; Gilson AM; Bryan G; Augustine C; Gassman M; Mott DA
    Res Social Adm Pharm; 2021 Jul; 17(7):1332-1341. PubMed ID: 33268242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A qualitative study of community pharmacists' opinions on the provision of osteoporosis disease state management services in Malaysia.
    Nik J; Lai PS; Ng CJ; Emmerton L
    BMC Health Serv Res; 2016 Aug; 16(1):448. PubMed ID: 27577560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
    Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
    BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
    Yong FR; Hor SY; Bajorek BV
    BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related stakeholders' perceptions of clinical pharmacy services in Qatar.
    Jebara T; Cunningham S; MacLure K; Awaisu A; Pallivalapila A; Al Hail M; Stewart D
    Int J Clin Pharm; 2021 Feb; 43(1):107-117. PubMed ID: 32960428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rural health systems' perceptions of referral to community pharmacists during transitions of care.
    Paul S; DiDonato KL; Liu Y; Hartwig DM; May J; Schramm AM
    J Am Pharm Assoc (2003); 2016; 56(5):562-567.e2. PubMed ID: 27475835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A national study into the rural and remote pharmacist workforce.
    Smith JD; White C; Roufeil L; Veitch C; Pont L; Patel B; Battye K; Luetsch K; Mitchell C
    Rural Remote Health; 2013; 13(2):2214. PubMed ID: 23683357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding pharmacists' roles: Pharmacists' perspectives on barriers and facilitators to collaborative practice.
    Lott BE; Anderson EJ; Villa Zapata L; Cooley J; Forbes S; Taylor AM; Manygoats T; Warholak T
    J Am Pharm Assoc (2003); 2021; 61(2):213-220.e1. PubMed ID: 33359117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gap analysis of pharmacist communication with community-based oral health care providers.
    Woodworth KG; Sanders KA
    J Am Pharm Assoc (2003); 2021; 61(3):e119-e126. PubMed ID: 33531262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Care of the stroke patient-communication between the community pharmacist and prescribers in the Republic of Ireland.
    Grimes T; Duggan C; Gallagher P; Strawbridge J
    Pharm World Sci; 2009 Dec; 31(6):648-55. PubMed ID: 19757142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.